Trial
NCT06961266
A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Jazz Pharmaceuticals
Collaborators
Jazz Pharmaceuticals Ireland Limited
Condition
Narcolepsy
Intervention
JZP441
Why stopped
The study was terminated based on a business decision by the Sponsor.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-06